Aciclovir Intravenous (DBL) is a medicine containing the active ingredient(s) aciclovir. On this page you will find out more about Aciclovir Intravenous (DBL), including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: aciclovir
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Aciclovir Intravenous (DBL) 500 mg/20 mL injection solution, 5 x 20 mL vials
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
Aciclovir Intravenous Infusion is indicated for the purpose of 1. Promoting resolution of acute clinical manifestations of mucocutaneous Herpes simplex virus infections in immunocompromised patients. 2. Treatment of severe first episode primary or non- primary genital herpes in immune competent patients. 3. Treatment of acute manifestations of Varicella zoster virus infection in immunocompromised patients. 4. Treatment of shingles (Varicella zoster virus infection) in immune competent patients who show very severe acute local or systemic manifestations of the disease. Benefits can be expected in patients with rash duration shorter than 72 hours. The use of the intravenous infusion may be warranted in only a small subgroup of immune competent patients with shingles. 5. Treatment of Herpes simplex encephalitis.
Table of characteristics
|Visual appearance||Clear, colourless or almost colourless solution, free from visible particulate matter.|
|Dosage Form||Injection, solution|
|Route of administration||Intravenous Infusion|
5 x 20mL: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 25 degrees Celsius|
|Storage conditions||Do not Refrigerate|
|Life time||2 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Found 1 results
DBL Aciclovir Intravenous Infusion (Concentrate for infusion) - myDr.com.au
DBL Aciclovir Intravenous Infusion (Concentrate for infusion) - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Found 0 results